{"slug":"news","tag":"news","variants":["news"],"description":"Collections that report oncology news.","count":18,"kinds":{"collection":18},"related":[{"slug":"source","tag":"source","shared":18},{"slug":"data","tag":"data","shared":1}],"records":[{"id":"src-asco-post","kind":"collection","name":"The ASCO Post","route":"/collections/src-asco-post/","tldr":"The ASCO Post gives reliable, clinician-written summaries of the trials that matter, usually within days."},{"id":"src-onclive","kind":"collection","name":"OncLive","route":"/collections/src-onclive/","tldr":"OncLive, run by MJH Life Sciences, publishes daily oncology news, approval alerts and video interviews with trial investigators, often within hours of a readout. Industry-sponsored content is common, so check numbers against the primary source before relying on them."},{"id":"src-targeted-oncology","kind":"collection","name":"Targeted Oncology","route":"/collections/src-targeted-oncology/","tldr":"Targeted Oncology is OncLive's sibling with a biomarker and targeted-therapy focus."},{"id":"src-cancer-network","kind":"collection","name":"CancerNetwork (ONCOLOGY)","route":"/collections/src-cancer-network/","tldr":"CancerNetwork publishes daily practice-oriented news across solid and haematologic cancers."},{"id":"src-cancer-letter","kind":"collection","name":"The Cancer Letter","route":"/collections/src-cancer-letter/","tldr":"The Cancer Letter tells the inside story of cancer institutions and policy. Nobody else covers NCI and the centres this closely."},{"id":"src-endpoints-news","kind":"collection","name":"Endpoints News","route":"/collections/src-endpoints-news/","tldr":"Endpoints News is the fastest read on what biotech and pharma are doing in oncology, deal by deal."},{"id":"src-fierce-biotech","kind":"collection","name":"Fierce Biotech","route":"/collections/src-fierce-biotech/","tldr":"Fierce Biotech is where trial failures get reported plainly."},{"id":"src-stat-news","kind":"collection","name":"STAT News","route":"/collections/src-stat-news/","tldr":"STAT News has the best-written reporting on the science and business of cancer, with real scepticism."},{"id":"src-biocentury","kind":"collection","name":"BioCentury","route":"/collections/src-biocentury/","tldr":"BioCentury writes analysis for people who make decisions about pipelines."},{"id":"src-evaluate","kind":"collection","name":"Evaluate Vantage","route":"/collections/src-evaluate/","tldr":"Evaluate Vantage forecasts which drugs and modalities will matter commercially in the next decade."},{"id":"src-adc-review","kind":"collection","name":"ADC Review","route":"/collections/src-adc-review/","tldr":"ADC Review covers everything ADC: deals, payload chemistry, and monthly pipeline summaries."},{"id":"src-urotoday","kind":"collection","name":"UroToday","route":"/collections/src-urotoday/","tldr":"UroToday is the prostate, bladder, and kidney cancer feed, including PSMA and radioligand news."},{"id":"src-oncodaily","kind":"collection","name":"OncoDaily","route":"/collections/src-oncodaily/","tldr":"OncoDaily publishes a high volume of daily oncology news, education and career items from outside the United States, which is the perspective US-centred feeds lack. It is free, but trial news is mixed with profiles and history pieces, so check primary sources before reusing a figure."},{"id":"src-healio-hemonc","kind":"collection","name":"Healio Hematology/Oncology","route":"/collections/src-healio-hemonc/","tldr":"Healio Hematology/Oncology publishes clinician-facing daily news with good approval and lifestyle-risk coverage."},{"id":"src-medscape-oncology","kind":"collection","name":"Medscape Oncology","route":"/collections/src-medscape-oncology/","tldr":"Medscape Oncology publishes broad clinician news with continuing-education tie-ins."},{"id":"src-biopharma-dive","kind":"collection","name":"BioPharma Dive","route":"/collections/src-biopharma-dive/","tldr":"BioPharma Dive offers clean, free industry reporting and is good for deal and approval context."},{"id":"src-asco-daily-news","kind":"collection","name":"ASCO Daily News","route":"/collections/src-asco-daily-news/","tldr":"ASCO Daily News is the American Society of Clinical Oncology's free news service, published daily during meetings and weekly otherwise, covering sessions as they happen and guideline updates. It is most useful during the Annual Meeting, when it adds expert perspective to the abstracts."},{"id":"src-nature-briefing-cancer","kind":"collection","name":"Nature Briefing: Cancer","route":"/collections/src-nature-briefing-cancer/","tldr":"Nature Briefing: Cancer is one email a week that catches the papers you missed."}]}